N F Beliaeva

Author PubWeight™ 0.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Zebrafish as a model organism for biomedical studies]. Biomed Khim 2011 0.82
2 [Purification of commercial preparations of NADP from AMP]. Vopr Med Khim 1983 0.75
3 [Changes in the level of fructose-2,6-biphosphate in peripheral blood lymphocytes in patients with diabetes mellitus]. Vopr Med Khim 1999 0.75
4 [Lysozyme content in the saliva of healthy children and children with stomatitis]. Stomatologiia (Mosk) 1973 0.75
5 [Comparative characteristics of vanadium-containing compounds, possessing insulin-like effects]. Vopr Med Khim 2000 0.75
6 [Study of proteomic profile of Danio rerio embryos using one-dimensional electrophoresis and mass spectrometry]. Biomed Khim 2012 0.75
7 [The fructose-2,6-diphosphate system and diabetes mellitus]. Klin Lab Diagn 1994 0.75
8 [Complex type of kinetics of fructose-1,6-diphosphate from the rat and rabbit liver]. Biokhimiia 1985 0.75
9 [Functional characteristics of fructose-2,6-bisphosphate system in the liver during experimental streptozotocin diabetes]. Vopr Med Khim 1997 0.75
10 [The importance of passive immunity to respiratory and intestinal viruses in early childhood]. Akush Ginekol (Mosk) 1967 0.75
11 [Relation between Mg2+ activation and AMP inhibition of fructose-1,6-diphosphatase from rabbit skeletal muscles]. Biokhimiia 1987 0.75
12 [Anticancer activity of oxovanadium compounds]. Biomed Khim 2013 0.75
13 [Modern approaches to pharmacotherapy of diabetes mellitus type II]. Vopr Med Khim 2002 0.75
14 [Fructose-2,6-bisphosphate system and experimental states]. Vestn Ross Akad Med Nauk 1995 0.75
15 [Determination of fructose-2,6-biphosphate in human peripheral blood lymphocytes--a potential clinico-laboratory test in diabetology]. Biull Eksp Biol Med 1996 0.75
16 [Synthesis and hypoglycemic activity of bis(L-malato)oxovanadium(IV)]. Biomed Khim 2011 0.75
17 [Desensitization with acetylsalicylate and salicylate of fructose-1,6-diphosphatase from the rabbit liver and skeletal muscles to allosteric inhibition of AMP]. Vopr Med Khim 1986 0.75
18 [Determination of the concentration of fructose-2,6-bisphosphate using phosphofructokinase]. Lab Delo 1990 0.75
19 [Isolation of the islands of Langerhans from rat pancreas and determination of proteolytic activity in them]. Vopr Med Khim 1977 0.75
20 [Spontaneous fluctuations in the activity of rabbit skeletal muscle NAD-kinase]. Biull Eksp Biol Med 1976 0.75
21 [Studies on passive immunity to respiratory viruses under experimental conditions]. Akush Ginekol (Mosk) 1966 0.75
22 [Comparative kinetic properties of structure-bound and solubilized L-threonine dehydratase from brewer's yeast]. Biokhimiia 1979 0.75
23 [The mechanism of rat liver fructose-1,6-bisphosphate inhibition by fructose-2,6-bisphosphate]. Biokhimiia 1989 0.75
24 [The allosteric nature of substrate inhibition of rabbit skeletal muscle fructose-1,6-diphosphatase]. Biokhimiia 1990 0.75
25 [Various regulatory properties of fructose-1,6-diphosphatase of the rat liver under normal conditions and in experimental autoimmune cardiomyopathy]. Vopr Med Khim 1986 0.75
26 [Nicotinamide nucleotide content and rate of synthesis of NADP in rabbit muscles during embryonal and postnatal development]. Zh Evol Biokhim Fiziol 1974 0.75
27 [Certain properties of "biosynthetic" L-threonine dehydratase from subcellular structures of brewers' yeast Saccharomyces carlsbergensis]. Ukr Biokhim Zh (1978) 1981 0.75